X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Manufacturing and Distribution of ALCON

Yuvraj_pawp by Yuvraj_pawp
5th October 2015
in Manufacturing

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

What We Do
In an environment where quality and precision are critical, we employ professionals with the skills and passion to meet the expectations of our customers, as well as the regulatory bodies that govern the development and manufacturing of our eye care products.

Good Manufacturing Practices
Alcon’s Manufacturing and Technical Operations (MTO) organization is a network of nearly 14,000 individuals dedicated to producing and delivering the innovative eye care products that our customers and patients rely on. We operate 23 state-of-the art manufacturing and distribution facilities around the world, designed to ensure a reliable supply of quality eye care products.

What We Manufacture
Our manufacturing and distribution facilities are categorized by product type, dedicated to surgical equipment and devices, pharmaceuticals, and vision care products.

Surgical Devices and Equipment
Alcon manufactures technologies and devices for cataract, retinal, glaucoma and refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, like presbyopia and astigmatism. We also manufacture advanced viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery.

Pharmaceuticals
Alcon manufactures products that treat elevated intraocular pressure for people with glaucoma; products to treat eye and ear infections; and ophthalmic solutions to treat inflammation and pain associated with ocular surgery. We also manufacture eye and nasal allergy treatments, and over-the-counter dry eye relief and ocular vitamins.

Vision Care Products
At our Vision Care facilities, we manufacture daily disposable, monthly replacement and color-enhancing contact lenses. We also manufacture a complete line of contact lens care products, including multi-purpose and hydrogen-peroxide based solutions, rewetting drops, and daily protein removers.

Quality and Safety Standards
Patients are at the center of everything we do and at the heart of our commitment to quality. From research and development, to manufacturing and distribution, unparalleled quality and safety standards are the keys to our success.

Alcon adheres to the strictest of regulatory and statutory requirements, while also seeking continual improvement and advancement in the way we develop and manufacture our products. This is reflected in every aspect of our business, our partner relationships and our customers’ satisfaction.

Continuous Improvement
Alcon operates a continuous improvement program that involves activities such as quality improvements and cycle-time reductions. We also make sure to maintain good manufacturing practices through consistent training of our associates in topics such as management, safety, and regulatory and technical issues.

Previous Post

Takeda to Highlight Ixazomib Clinical Development Program at Upcoming International Myeloma Workshop

Next Post

Manufracturing of Sun Pharma

Related Posts

FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Insights

Green Chemistry in Sustainable API Manufacturing

26th September 2025
active pharmaceutical ingredients supply chain
Drug Development

Future of Active Pharmaceutical Ingredients Supply

26th September 2025
pharmaceutical excipients for new therapies
Drug Development

Advances in Pharmaceutical Excipients for New Therapies

26th September 2025
Next Post

Manufracturing of Sun Pharma

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In